News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,605 Results
Type
Article (88503)
Company Profile (814)
Press Release (789256)
Multimedia
Podcasts (224)
Webinars (34)
Section
Business (233468)
Career Advice (4156)
Deals (39936)
Drug Delivery (172)
Drug Development (91588)
Employer Resources (207)
FDA (18500)
Job Trends (17465)
News (398443)
Policy (40014)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (48)
Adcomms (37)
Allergies (181)
Alliances (56986)
ALS (213)
Alzheimer's disease (1907)
Antibody-drug conjugate (ADC) (480)
Approvals (18769)
Artificial intelligence (776)
Autoimmune disease (278)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (233)
Biotechnology (486)
Bladder cancer (193)
Brain cancer (78)
Breast cancer (757)
Cancer (5991)
Cardiovascular disease (516)
Career advice (3587)
Career pathing (48)
CAR-T (348)
CDC (73)
Celiac Disease (2)
Cell therapy (959)
Cervical cancer (47)
Clinical research (78194)
Collaboration (2200)
Company closure (7)
Compensation (1372)
Complete response letters (100)
COVID-19 (3022)
CRISPR (115)
C-suite (1138)
Cystic fibrosis (162)
Data (7707)
Decentralized trials (3)
Denatured (84)
Depression (183)
Dermatology (73)
Diabetes (613)
Diagnostics (7471)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (384)
Drug pricing (241)
Drug shortages (39)
Duchenne muscular dystrophy (292)
Earnings (101566)
Editorial (75)
Employer branding (25)
Employer resources (174)
Events (137108)
Executive appointments (1138)
FDA (22255)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1803)
Gene editing (251)
Generative AI (85)
Gene therapy (786)
GLP-1 (1228)
Government (5530)
Grass and pollen (8)
Guidances (408)
Healthcare (21065)
HIV (86)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (337)
Immuno-oncology (98)
Indications (171)
Infectious disease (3391)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (289)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (109)
Layoffs (673)
Leadership (48)
Legal (10170)
Liver cancer (107)
Longevity (33)
Lung cancer (797)
Lymphoma (430)
Machine learning (62)
Management (66)
Manufacturing (1087)
MASH (197)
Medical device (15195)
Medtech (15288)
Mergers & acquisitions (23175)
Metabolic disorders (1642)
mRNA (233)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (446)
Neuropsychiatric disorders (121)
Neuroscience (3503)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (76)
Obesity (798)
Opinion (364)
Ovarian cancer (214)
Pain (265)
Pancreatic cancer (298)
Parkinson's disease (379)
Partnered (39)
Patents (602)
Patient recruitment (662)
Peanut (66)
People (67610)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24159)
Phase 2 (33957)
Phase 3 (25545)
Pipeline (7990)
Policy (379)
Postmarket research (3557)
Preclinical (10875)
Press Release (72)
Prostate cancer (301)
Psychedelics (65)
Radiopharmaceuticals (347)
Rare diseases (1154)
Real estate (7451)
Recruiting (81)
Regulatory (29917)
Reports (76)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (36)
RNA editing (25)
RSV (98)
Schizophrenia (186)
Series A (302)
Series B (221)
Service/supplier (30)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (187)
Sponsored (54)
Startups (4355)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (137)
Vaccines (1250)
Venture capital (116)
Weight loss (551)
Women's health (127)
Worklife (24)
Date
Today (172)
Last 7 days (730)
Last 30 days (2938)
Last 365 days (33168)
2026 (10937)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57665)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (100)
Alaska (7)
Arizona (381)
Arkansas (16)
Asia (51999)
Australia (9143)
California (13253)
Canada (3760)
China (1399)
Colorado (573)
Connecticut (585)
Delaware (403)
Europe (119785)
Florida (1966)
Georgia (433)
Hawaii (4)
Idaho (69)
Illinois (1141)
India (97)
Indiana (622)
Iowa (25)
Japan (532)
Kansas (138)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1623)
Massachusetts (9675)
Michigan (400)
Minnesota (745)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (145)
New Hampshire (92)
New Jersey (3548)
New Mexico (33)
New York (3506)
North Carolina (1800)
North Dakota (10)
Northern California (6502)
Ohio (408)
Oklahoma (26)
Oregon (55)
Pennsylvania (2641)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5172)
Tennessee (210)
Texas (2137)
United States (47606)
Utah (396)
Vermont (1)
Virginia (338)
Washington D.C. (88)
Washington State (1096)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
There are 878,605 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
FDA alleges ‘manipulated’ data supported approval of Amgen’s autoimmune drug
The FDA has renewed calls for Amgen’s Tavneos to be pulled from the market, saying it has discovered new evidence that study personnel doctored the results of the drug’s pivotal study in order to make it look effective.
April 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea
Heterologous approach aims to deliver targeted, broad-spectrum immune response to Neisseria gonorrhoeae infections
April 28, 2026
·
1 min read
Events
Symposium: Advancing GCT Translation From IIT to IND Submission
We invite you to join an IIT‑to‑IND CGT forum Monday evening around ASGCT & PEGS.
April 28, 2026
Press Releases
Omnicell Announces First Quarter 2026 Financial Results
April 28, 2026
·
19 min read
Press Releases
Zimmer Biomet Announces Chief Financial Officer Transition
April 28, 2026
·
4 min read
Press Releases
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
April 28, 2026
·
10 min read
Press Releases
Zimmer Biomet Announces First Quarter 2026 Financial Results
April 28, 2026
·
30 min read
Press Releases
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication for ATI-2138, an Oral ITK/JAK3 Inhibitor
April 28, 2026
·
12 min read
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
April 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Lighthouse Pharmaceuticals Closes $12 Million Series A Financing Led by Double Point Ventures
April 28, 2026
·
2 min read
1 of 87,861
Next
